Publications found:
254
Sort by:
Learning Disabilities Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Auditory Processing Disorder (APD), Dyscalculia, Dysgraphia, Dyslexia, Language Processing Disorder, Others), By Treatment (Assistive Technology Tools (ATT), Handwriting Training Tools, Therapy, Others), By End User (Homecare, Specialty Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Learning Disabilities Treatment Market is projected to expand from USD 21.43 Billion in 2025 to USD 31.16 Billion by 2031, registering a CAGR of 6.44%. This market comprises pharmaceutical...
January 2026
185 pages
Schizophrenia Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), By Route Of Administration (Injectable, Oral), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Schizophrenia Drugs Market is projected to expand from USD 6.45 Billion in 2025 to USD 8.48 Billion by 2031, registering a compound annual growth rate of 4.67%. This market encompasses a va...
January 2026
180 pages
Epilepsy Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drugs (First Generation Anti-epileptics, Second Generation Anti-epileptics, Third Generation Anti-epileptics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), By Region & Competition,, 2021-2031F
US$ 4,500.00
The Global Epilepsy Drugs Market is projected to expand from USD 7.16 Billion in 2025 to USD 8.59 Billion by 2031, reflecting a CAGR of 3.08%. This industry sector encompasses the development and sale...
January 2026
186 pages
Multiple System Atrophy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis (Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Tilt Table Test, Others), By Age (Pediatric, Adults, Geriatric), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Multiple System Atrophy Market is projected to expand from USD 154.39 Million in 2025 to USD 185.53 Million by 2031, reflecting a Compound Annual Growth Rate of 3.11%. This market involves...
January 2026
180 pages
Post-traumatic Stress Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Antidepressants, Antipsychotics, Anti-anxiety, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Post-traumatic Stress Disorder Treatment Market is projected to expand from USD 969.39 Million in 2025 to USD 1280.63 Million by 2031, registering a CAGR of 4.75% during the forecast period...
January 2026
181 pages
Narcolepsy Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Narcolepsy with Cataplexy, Narcolepsy Without Cataplexy, Secondary Narcolepsy), By Product (Central Nervous System Stimulants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Tricyclic Antidepressants, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Narcolepsy Therapeutics Market is projected to expand from a valuation of USD 3.42 Billion in 2025 to USD 5.09 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 6.85%. The...
January 2026
180 pages
Disruptive Behavior Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Oppositional Defiant Disorder, Conduct Disorder, and Intermittent Explosive Disorder), By Treatment (Medication Management, Comprehensive Evaluation, Family Therapy, Parenting Modification, Group Therapy, Individual Therapy, and Social and Emotional Skills Training), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Disruptive Behavior Disorder Treatment Market is projected to expand from USD 1.86 million in 2025 to USD 2.57 million by 2031, registering a compound annual growth rate of 5.54%. This mark...
January 2026
180 pages
Alzheimer's Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Cholinesterase Inhibitors {Donepezil, Galantamine, Rivastigmine}, NMDA Receptor Antagonist, Combination Drugs, Pipeline Drugs), By End User (Hospital Pharmacy, Retail Pharmacy, E-commerce), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Alzheimer?s Therapeutics Market is projected to expand from USD 4.92 Billion in 2025 to USD 7.77 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.92%. Alzheimer?s thera...
January 2026
186 pages
Central Nervous System Therapeutics Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Multiple Sclerosis, Antipsychotic, Antiepileptics, Analgesics & Anesthetics, Anti-Parkinson, Others), By Application (Neurodegenerative Diseases, Mental Health and Trauma, Neurovascular Diseases, Infectious Diseases, CNS Cancer, Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospital, Clinics, Diagnostic Laboratories, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Central Nervous System Therapeutics Market is projected to expand from USD 115.21 billion in 2025 to USD 182.42 billion by 2031, reflecting a CAGR of 7.96%. These therapeutics consist of ph...
January 2026
185 pages
Lewy Body Dementia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), By Drug Type (Cholinesterase Inhibitors, Antipsychotic Drugs, Carbidopa-Levodopa, Antidepressants, Benzodiazepine, Modafinil), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Lewy Body Dementia Treatment Market is projected to expand from USD 5.24 Billion in 2025 to USD 7.72 Billion by 2031, reflecting a compound annual growth rate of 6.67%. This market covers p...
January 2026
185 pages
The 2027-2032 World Outlook for Lou Gehrig's Disease Drugs
US$ 1,195.00
... study covers the world outlook for Lou Gehrig's Disease drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for Lou Gehrig's Disease drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
Global Narcolepsy Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... Market Segment by Applications, can be divided into Daytime Extreme Sleepiness Cataplexia Others There are 15 Chapters to deeply display the global Narcolepsy Drug market. Chapter 1, to describe Narcolepsy Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Narcolepsy Drug, with ...
January 2026
77 pages
Global Perphenazine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... from 95 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Perphenazine in global market, especially in North America, Europe ... growth rate by type, application, from 2014 to 2019. Chapter 12, Perphenazine market forecast, by regions, type and application, with ...
January 2026
100 pages
Global Neuromyelitis Optica Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... manufacturers of Neuromyelitis Optica Drug, with price, sales, revenue and global market share of Neuromyelitis Optica Drug in 2017 and 2018. Chapter 3, the Neuromyelitis Optica Drug competitive situation, sales, revenue and global market share ...
January 2026
116 pages
The 2027-2032 World Outlook for CNS Therapeutics
US$ 1,195.00
This study covers the world outlook for CNS therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
288 pages
Sleep Disorder Treatment Market - Forecast from 2026 to 2031
US$ 3,950.00
The sleep disorder treatment market is forecasted to achieve a 10.23% CAGR, reaching USD 35.666 billion in 2031 from USD 19.878 billion in 2025. The sleep disorder treatment market is witnessing risin...
January 2026
148 pages
Gabapentin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Form (Tablet, Capsule, Oral Solution), By Type (Generic, Branded), By Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Gabapentin Market, valued at USD 2.04 Billion in 2024, is projected to experience a CAGR of 5.60% to reach USD 2.83 Billion by 2030. Gabapentin, an anticonvulsant medication, is primarily u...
December 2025
185 pages
Autism Spectrum Disorders Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants, Sleep Medication, Others), By Application (Autistic Disorder, Asperger Syndrome, Pervasive Development Disorder, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Autism Spectrum Disorders Treatment Market, valued at USD 1.71 Billion in 2024, is projected to experience a CAGR of 5.39% to reach USD 2.34 Billion by 2030. The Global Autism Spectrum Diso...
December 2025
185 pages
U.S. Autism Spectrum Disorder Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Antipsychotic Drugs, Stimulants, Sleep Medications, Selective Serotonin Reuptake Inhibitors), By Application, By Distribution Channel, And Segment Forecasts, 2025 - 2033
US$ 3,950.00
The U.S. autism spectrum disorder treatment market size was estimated at USD 827.84 million in 2024 and is projected to reach USD 1,431.60 million by 2033, growing at a CAGR of 6.30% from 2025 to 2033...
November 2025
120 pages
Insomnia Drug Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists, Others), By Application (Over-the- Counter Drugs, Prescription Drugs), By Distribution Channel
US$ 3,950.00
The Insomnia Drug Market is valued at USD 2.95 billion in 2025 and is projected to grow at a CAGR of 5.1% to reach USD 4.62 billion by 2034. Insomnia Drug Market The Insomnia Drug market spans prescri...
November 2025
160 pages
Benzodiazepine Drugs Market Size, Share & Trends Analysis Report By Application (Anxiety Disorders, Insomnia & Sleep Disorders), By Product (Diazepam, Lorazepam, Alprazolam, Clonazepam), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global benzodiazepine drugs market size was estimated at USD 2.83 billion in 2024 and is projected to reach USD 3.85 billion by 2033, growing at a CAGR of 3.48% from 2025 to 2033. The industry is...
November 2025
150 pages
Benzodiazepine Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Alprazolam, Diazepam, Lorazepam, Clonazepam, Temazepam, Oxazepam, Chlordiazepoxide, Other Products), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Application, By End User
US$ 3,950.00
The Benzodiazepine Drugs Market is valued at USD 4.5 billion in 2025 and is projected to grow at a CAGR of 7.4% to reach USD 8.5 billion by 2034.The benzodiazepine drugs market remains a critical comp...
October 2025
160 pages
